Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial
暂无分享,去创建一个
C. K. Yao | D. Kaye | F. Marques | Hamdi A. Jama | Dakota Rhys-Jones | M. Nakai | D. Creek | Dovile Anderson | Y. Sata | R. Climie | H. Jama | D. Rhys-Jones | G. Head | C. Mackay | J. Muir
[1] M. V. van Zelm,et al. A randomized dietary intervention to increase colonic and peripheral blood SCFAs modulates the blood B- and T-cell compartments in healthy humans , 2022, The American journal of clinical nutrition.
[2] S. Juraschek,et al. Increases in Circulating and Fecal Butyrate are Associated With Reduced Blood Pressure and Hypertension: Results From the SPIRIT Trial , 2022, Journal of the American Heart Association.
[3] A. El-Osta,et al. Maternal diet and gut microbiota influence predisposition to cardiovascular disease in the offspring , 2022, bioRxiv.
[4] C. K. Yao,et al. Supplementing dietary fibres with a low FODMAP diet in irritable bowel syndrome: a randomized controlled crossover trial , 2021, Clinical Gastroenterology and Hepatology.
[5] Chris I. Hunter,et al. Reporting guidelines for human microbiome research: the STORMS checklist , 2021, Nature Medicine.
[6] Gretchen A. Stevens,et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants , 2021, The Lancet.
[7] M. Carrington,et al. The Gut Microbiome of Heart Failure With Preserved Ejection Fraction , 2021, Journal of the American Heart Association.
[8] B. Tang,et al. Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration , 2021, Microbiome.
[9] M. Carrington,et al. Essential Hypertension Is Associated With Changes in Gut Microbial Metabolic Pathways , 2021, medRxiv.
[10] J. Muir,et al. Microbial Interventions to Control and Reduce Blood Pressure in Australia (MICRoBIA): rationale and design of a double-blinded randomised cross-over placebo controlled trial , 2021, Trials.
[11] T. Kuwahara,et al. Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health , 2021, Gut microbes.
[12] M. V. van Zelm,et al. Delivery of Acetate to the Peripheral Blood after Consumption of Foods High in Short-Chain Fatty Acids. , 2020, Molecular nutrition & food research.
[13] K. Whelan,et al. Dietary fibre in gastrointestinal health and disease , 2020, Nature Reviews Gastroenterology & Hepatology.
[14] C. K. Yao,et al. Effects of fiber intake on intestinal pH, transit, and predicted oral mesalamine delivery in patients with ulcerative colitis , 2020, Journal of gastroenterology and hepatology.
[15] Dan J Stein,et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.
[16] R. Valls,et al. Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study , 2020, Scientific Reports.
[17] G. Celano,et al. The Controversial Role of Human Gut Lachnospiraceae , 2020, Microorganisms.
[18] T. Spector,et al. Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease , 2020, Circulation.
[19] L. Lerman,et al. Coronary artery disease is associated with an altered gut microbiome composition , 2020, PloS one.
[20] Jianguo Xia,et al. Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data , 2020, Nature Protocols.
[21] G. Stergiou,et al. May Measurement Month 2019 The Global Blood Pressure Screening Campaign of the International Society of Hypertension , 2020 .
[22] C. Mackay,et al. Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension. , 2019, Hypertension.
[23] Francesco Asnicar,et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.
[24] L. T. Te Morenga,et al. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses , 2019, The Lancet.
[25] M. Grandoch,et al. Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage , 2018, Circulation.
[26] M. V. van Zelm,et al. Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders , 2018, Alimentary pharmacology & therapeutics.
[27] C. Pepine,et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. , 2018, Clinical science.
[28] D. Harrison,et al. The immunology of hypertension , 2018, The Journal of experimental medicine.
[29] C. Mackay,et al. Beyond gut feelings: how the gut microbiota regulates blood pressure , 2018, Nature Reviews Cardiology.
[30] James L. Richards,et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes , 2017, Nature Immunology.
[31] A. El-Osta,et al. High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice , 2017, Circulation.
[32] J. Raes,et al. Population-level analysis of gut microbiome variation , 2016, Science.
[33] M. Biddle,et al. A report from the American Heart Association Council on Cardiovascular and Stroke Nursing. , 2015, The Journal of cardiovascular nursing.
[34] William A. Walters,et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.
[35] C. Mackay,et al. Diet, gut microbiota and immune responses , 2010, Nature Immunology.
[36] B. Heran,et al. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension. , 2008, The Cochrane database of systematic reviews.
[37] Pedagógia,et al. Cross Sectional Study , 2019 .
[38] L. Cobiac,et al. Excretion of starch and esterified short-chain fatty acids by ileostomy subjects after the ingestion of acylated starches. , 2007, The American journal of clinical nutrition.
[39] D. Topping,et al. Acetylated, propionylated or butyrylated starches raise large bowel short-chain fatty acids preferentially when fed to rats. , 2003, The Journal of nutrition.
[40] G. Bray,et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.
[41] C. Nutting,et al. Vasorelaxant effects of short chain fatty acid salts in rat caudal artery. , 1991, The American journal of physiology.
[42] M. Mulvany,et al. Short chain fatty acids dilate isolated human colonic resistance arteries. , 1990, Gut.
[43] M Marmot,et al. INTERSALT Study Findings Public Health and Medical Care Implications , 1989, Hypertension.